ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy

Background: Pathophysiology of acute encephalopathy in cirrhotic patients is not completely understood. Factors implicated include ammonia, inflammation, various metabolic disorders and drug toxicity. Recent studies have evidenced an increased permeability of the blood-brain barrier (BBB) in models of chronic liver disease and encephalopathy, either to solutes, or to leu-kocytes. A modification of the expression of BBB ATP-Binding Cassette (ABC) transporters, actively transporting endogenous and exogenous components through the BBB, has been described in models of acute liver failure. We hypothesized that a modification of ABC transport-ers expression may contribute to drug-induced acute encephalopathy in cirrhosis. Materiel and methods: A rat model of cirrhosis induced by Bile Duct Ligation (BDL) was studied, and compared to a SHAM rat model. Rats were sacrificed and brains studied after decapitation. Genic expression of ABC transporters, including P-gp, BCRP, MRP1, MRP2, MRP4 and MRP5 was evaluated by RT-qPCR on isolated brain microvessels. Encephalopathy was assessed 6 weeks after surgery by a trail suspension test and an Open Field Test. Results: BDL rats developed a histologically proven cirrhosis and displayed a higher ammonemia than SHAM rats (183 mmol/L vs 53 mmol/L, p = 0.0003). BDL rats presented with encephalopathy shown by neurobehavioral tests. MRP2 was not detected neither in BDL nor in SHAM rats. There was a decrease in the genic expression of MRP5 6 weeks after surgery. Expressions of P-gp, BCRP, MRP1 and MRP4 were not different between the 2 groups. Conclusion: We suggest that acute encephalopathy in cirrhotic BDL rats may be associated to a modification of ABC transporter MRP5 on the BBB, that could be responsible for a decrease clearance of neurotoxic agents. (C) 2021 Published by Elsevier Masson SAS.

Automated summary

The pathophysiology of acute encephalopathy in cirrhotic patients is not fully understood. Recent studies have indicated increased permeability of the blood-brain barrier (BBB) in models of chronic liver disease and encephalopathy. This study focused on the modification of ATP-binding cassette (ABC) transporters in the BBB and found a possible association between the expression of MRP5 and drug-induced acute encephalopathy in cirrhosis.